• Price (EUR)24.72
  • Today's Change0.06 / 0.24%
  • Shares traded4.86k
  • 1 Year change-11.08%
  • Beta--
Data delayed at least 15 minutes, as of Mar 27 2023 15:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through the segment, which consists of investments in healthcare-related real estate properties located in the United States and the United Kingdom. The Company's core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). The Company's portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. Its portfolio of real estate investments includes over 926 healthcare facilities, located in 42 states and the United Kingdom that are operated by 67 third-party operators.

  • Revenue in USD (TTM)878.24m
  • Net income in USD426.93m
  • Incorporated1992
  • Employees52.00
  • Location
    Omega Healthcare Investors IncSUITE 3500, 200 INTERNATIONAL CIRCLEHUNT VALLEY 21030United StatesUSA
  • Phone+1 (410) 427-1700
  • Fax+1 (410) 427-8800
  • Websitehttps://www.omegahealthcare.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
OHI:NYQ since
ApexonHealth LLCDeal completed13 Apr 202213 Apr 2022Deal completed-2.60%--
Data delayed at least 15 minutes, as of Mar 27 2023 15:36 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.